The duration of Bolivar cannot be generalized, but is closely related to the patient’s underlying condition. For example, it should be taken for 1 year after coronary stenting, while those with pure acute coronary syndrome without coronary stenting may only need to take it for 3 months. Bolivar is an anti-platelet aggregation drug, and the duration of treatment varies from person to person depending on the type and severity of the disease. After coronary stenting, a combination of aspirin and Polivir is required for 1 year. Polivir can be stopped after 1 year, but aspirin should be continued. Acute coronary syndromes without stenting require combined aspirin and poliovel therapy for 3 months, after which poliovel can be discontinued and aspirin alone should be continued. In addition, for patients with high thrombotic load or high risk of coronary artery disease, Polivic may be extended as appropriate for their condition. In addition, patients should be monitored for abnormal bleeding while taking Polivic; Polivic should be used with caution in patients with severe liver disease, pregnant women, and patients with bleeding disorders.